Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Drugs Made In America Acquisition II Corp.

NASDAQ: DMII · Real Estate & Construction · 1 alert · CIK 2040475

Sector
Real Estate & Construction
Industry
Blank ChecksSIC 6770

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Drugs Made In America Acquisition II Corp. filings on SEC EDGAR ↗

11:09 AM ET 8-K
M&A Deal

Drugs Made In America Acquisition II Signs $600M M&A Deal with Alpha AI Biotech Group

Drugs Made In America Acquisition II Corp. has delivered a preliminary proposal for a business combination with Alpha AI Biotech Group at a pre-money equity valuation of $600 million. The deal contemplates the issuance of 60 million shares at $10.00 each, plus up to 30 million earn-out shares based on post-closing stock performance. Additionally, the company received a $250,000 funding installment from Tal Alpha Yezum Vekidum Asakim (2003) Ltd. as part of a consolidated $700,000 convertible note facility.

Value
$600M
Counterparty
Alpha AI Biotech Group

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.